Precision BioSciences Inc (DTIL)
10.52
-0.32
(-2.95%)
USD |
NASDAQ |
May 03, 16:00
10.38
-0.14
(-1.38%)
After-Hours: 20:00
Precision BioSciences Profit Margin (Quarterly): -231.4% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -231.4% |
| September 30, 2023 | -61.58% |
| June 30, 2023 | -60.09% |
| March 31, 2023 | -285.4% |
| December 31, 2022 | -268.8% |
| September 30, 2022 | -325.2% |
| June 30, 2022 | -812.4% |
| March 31, 2022 | -849.2% |
| December 31, 2021 | -351.6% |
| September 30, 2021 | -46.93% |
| June 30, 2021 | 31.47% |
| March 31, 2021 | -114.3% |
| Date | Value |
|---|---|
| December 31, 2020 | -265.1% |
| September 30, 2020 | -353.3% |
| June 30, 2020 | -3.03K% |
| March 31, 2020 | -383.5% |
| December 31, 2019 | -320.7% |
| September 30, 2019 | -426.4% |
| June 30, 2019 | -360.7% |
| March 31, 2019 | -581.9% |
| December 31, 2018 | -312.6% |
| September 30, 2018 | -383.9% |
| June 30, 2018 | -631.1% |
| March 31, 2018 | -589.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.03K%
Minimum
Jun 2020
31.47%
Maximum
Jun 2021
-448.4%
Average
-320.7%
Median
Dec 2019
Profit Margin (Quarterly) Benchmarks
| Altimmune Inc | -85.52K% |
| BioVie Inc | -- |
| Adial Pharmaceuticals Inc | -- |
| Gritstone Bio Inc | -106.3K% |
| Humacyte Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -167.9% |
| Return on Assets | -32.32% |
| Return on Invested Capital | -104.2% |
| Operating Margin (Quarterly) | -211.6% |
| Return on Net Operating Assets | -197.7% |